CASP3 and breast carcinoma: Previous studies have demonstrated that the high caspase-3 expression is significantly associated with poor prognosis in patients with gastric cancer, ovarian cancer, cervical cancer, colorectal cancer, non-small cell lung cancer, hepatocellular carcinoma, and breast cancer [34–38].